This site is dedicated to saving the lives of men who are at high-risk for prostate cancer. The site and it’s blog will provide information about prostate cancer screening with the prostate specific antigen (PSA) blood test and the digital rectal examination (DRE) of the prostate gland. There has been controversy about the benefit of PSA screening due to recommendations from the United States Preventive Task Force, which was intended for the majority of US men who are at low risk. Most prostate cancer experts do not agree with that recommendation. However the statement was not intended for men at high risk, which includes men with a family history of prostate cancer or men with African ancestry (Blacks). We want to provide accurate information to these high-risk men so that they can be screened on a yearly basis beginning at age 40. This will allow for the early detection of prostate cancer and prevent unnecessary deaths by allowing the cancer to be treated before it becomes deadly.

This website has information about prostate cancer screening and prostate cancer research and is run by Dr. Adam Murphy, MD a urologist from Chicago, IL. Dr. Murphy has focused his clinical and research focus on prostate cancer and prostate cancer education.

*Supported by Specialized Program Of Research Excellence (SPORE) in Prostate Cancer at Northwestern University and the National Cancer Institute